ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
Trends in mortality from nutritional and metabolic diseases in the United States (1999-2020): An epidemiologic analysis using CDC WONDER. [PDF]
He J, Shuai X, Zhu H, Xia K.
europepmc +1 more source
Interactions between lipid droplets and mitochondria in metabolic diseases. [PDF]
Wang G +7 more
europepmc +1 more source
Myoclonus in Pediatric Metabolic Diseases: Clinical Spectrum, Mechanisms, and Treatable Causes-A Systematic Review. [PDF]
Majewska E +3 more
europepmc +1 more source
Rapid whole genome sequencing in newborn screening for metabolic diseases. [PDF]
Zheng J, Yang X.
europepmc +1 more source
m<sup>6</sup>A in adipose tissue inflammation: A novel regulator of obesity and metabolic diseases (Review). [PDF]
Yang X +5 more
europepmc +1 more source
The relationship between lifestyle, night shift pattern, mental health and the trajectories of nurses' metabolic diseases: a cohort study of nurses. [PDF]
Yang M, Che Y, Xu J, Ma X, Chen H, Li B.
europepmc +1 more source
Related searches:
Extracellular Vesicles in Metabolism and Metabolic Diseases
2021No description supplied
Akbar L, Marzan +2 more
openaire +2 more sources
Epitranscriptomics in metabolic disease
Nature Metabolism, 2023While epigenetic modifications of DNA and histones play main roles in gene transcription regulation, recently discovered post-transcriptional RNA modifications, known as epitranscriptomic modifications, have been found to have a profound impact on gene expression by regulating RNA stability, localization and decoding efficiency.
Yoshihiro Matsumura +2 more
openaire +2 more sources

